ISSN:
Journal Home
Journal Guideline
Molecular Cancer Therapeutics Q1 Unclaimed
American Association for Cancer Research Inc.
United States
Molecular Cancer Therapeutics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 190. It has a price of 3000 €. It has an SJR impact factor of 1,89 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,89.
Molecular Cancer Therapeutics focuses its scope in these topics and keywords: inhibitor, cancer, potent, cells, protein, resistance, activity, receptor, inhibition, vitro, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


Categories:
Cancer Research (Q1)
Oncology (Q1)
Price
3000 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,89
SJR Impact factor190
H Index170
Total Docs (Last Year)698
Total Docs (3 years)7123
Total Refs3947
Total Cites (3 years)687
Citable Docs (3 years)5.38
Cites/Doc (2 years)41.9
Ref/DocOther journals with similar parameters
CA - A Cancer Journal for Clinicians Q1
Molecular Cancer Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1
Compare this journals
Comments